Skip to main content
Erschienen in: World Journal of Surgery 6/2018

21.12.2017 | Original Scientific Report

Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil–Lymphocyte Ratio in Gastric Cancer Patients

verfasst von: Hiroaki Saito, Yusuke Kono, Yuki Murakami, Yuji Shishido, Hirohiko Kuroda, Tomoyuki Matsunaga, Yoji Fukumoto, Tomohiro Osaki, Keigo Ashida, Yoshiyuki Fujiwara

Erschienen in: World Journal of Surgery | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The ratio of C-reactive protein to albumin (CRP/Alb) is a biochemical marker of systemic inflammatory response and has been associated with poor survival in cancer. This study retrospectively investigated the relationship between the CRP/Alb ratio and prognosis in gastric cancer patients.

Methods

This study enrolled 453 patients with a histopathological diagnosis of gastric adenocarcinoma who underwent curative surgery.

Results

A statistically significant weak correlation was observed between CRP/Alb ratio and neutrophil/lymphocyte ratio (NLR) (r = 0.19; P < 0.0001). There were statistically significant correlations between high CRP/Alb ratio and age (P = 0.0004), tumor size (P = 0.02), depth of invasion (P = 0.012), and lymph node metastasis (P = 0.022). A high NLR was significantly correlated with age (P = 0.0027), tumor size (P = 0.0006), depth of invasion (P < 0.0001), lymphatic involvement (P = 0.0031), venous involvement (P = 0.0022), and stage of disease (P = 0.0024). Based on results by receiver operating characteristic analysis, patients were divided as follows: CRP/Alb ratio ≥ 0.0232 (CARHigh), CRP/Alb ratio < 0.0232 (CARLow), NLR ≥ 2.43 (NLRHigh), and NLR < 2.43 (NLRLow). Five-year survival rates of patients with both CARHigh and NLRHigh, either CARHigh or NLRHigh, and both CARLow and NLRLow were 59.6, 75.8, and 87.5%, respectively, with statistically significant differences (P < 0.0001). Multivariate analysis revealed that the combination of CRP/Alb ratio and NLR was an independent prognostic indicator.

Conclusions

The combination of CRP/Alb ratio and NLR may be useful in predicting prognosis in gastric cancer patients.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
2.
Zurück zum Zitat Park HJ, Ahn JY, Jung HY et al (2014) Clinical characteristics and outcomes for gastric cancer patients aged 18–30 years. Gastric Cancer 17:649–660CrossRefPubMed Park HJ, Ahn JY, Jung HY et al (2014) Clinical characteristics and outcomes for gastric cancer patients aged 18–30 years. Gastric Cancer 17:649–660CrossRefPubMed
3.
Zurück zum Zitat Nam DH, Lee YK, Park JC et al (2013) Prognostic value of early postoperative tumor marker response in gastric cancer. Ann Surg Oncol 20:3905–3911CrossRefPubMed Nam DH, Lee YK, Park JC et al (2013) Prognostic value of early postoperative tumor marker response in gastric cancer. Ann Surg Oncol 20:3905–3911CrossRefPubMed
5.
Zurück zum Zitat Kinoshita A, Onoda H, Imai N et al (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107:988–993CrossRefPubMedPubMedCentral Kinoshita A, Onoda H, Imai N et al (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107:988–993CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Inoue D, Ozaka M, Matsuyama M et al (2015) Prognostic value of neutrophil–lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan. Jpn J Clin Oncol 45:61–66CrossRefPubMed Inoue D, Ozaka M, Matsuyama M et al (2015) Prognostic value of neutrophil–lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan. Jpn J Clin Oncol 45:61–66CrossRefPubMed
7.
Zurück zum Zitat Fairclough E, Cairns E, Hamilton J et al (2009) Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med (Lond, Engl) 9:30–33CrossRef Fairclough E, Cairns E, Hamilton J et al (2009) Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med (Lond, Engl) 9:30–33CrossRef
8.
9.
Zurück zum Zitat Kinoshita A, Onoda H, Imai N et al (2015) The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol 22:803–810CrossRefPubMed Kinoshita A, Onoda H, Imai N et al (2015) The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol 22:803–810CrossRefPubMed
10.
Zurück zum Zitat Xu XL, Yu HQ, Hu W et al (2015) A novel inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS ONE 10:e0138657CrossRefPubMedPubMedCentral Xu XL, Yu HQ, Hu W et al (2015) A novel inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS ONE 10:e0138657CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Choi Y, Kim JW, Nam KH et al (2017) Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer. Gastric Cancer 20:602–611CrossRefPubMed Choi Y, Kim JW, Nam KH et al (2017) Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer. Gastric Cancer 20:602–611CrossRefPubMed
12.
Zurück zum Zitat Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef
13.
Zurück zum Zitat Bozzetti F, Bonfanti G, Morabito A et al (1986) A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet 162:229–234PubMed Bozzetti F, Bonfanti G, Morabito A et al (1986) A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet 162:229–234PubMed
14.
Zurück zum Zitat Maruyama K (1987) The most important prognostic factors for gastric cancer patients. Scand J Gastroenterol 22:63–68CrossRef Maruyama K (1987) The most important prognostic factors for gastric cancer patients. Scand J Gastroenterol 22:63–68CrossRef
15.
Zurück zum Zitat Morris-Stiff G, Gomez D, Prasad KR (2008) C-reactive protein in liver cancer surgery. Eur J Surg Oncol 34:727–729CrossRefPubMed Morris-Stiff G, Gomez D, Prasad KR (2008) C-reactive protein in liver cancer surgery. Eur J Surg Oncol 34:727–729CrossRefPubMed
16.
Zurück zum Zitat Yu Q, Yu XF, Zhang SD et al (2013) Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev APJCP 14:5735–5740CrossRefPubMed Yu Q, Yu XF, Zhang SD et al (2013) Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev APJCP 14:5735–5740CrossRefPubMed
17.
Zurück zum Zitat Detsky AS, McLaughlin JR, Baker JP et al (1987) What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11:8–13CrossRefPubMed Detsky AS, McLaughlin JR, Baker JP et al (1987) What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11:8–13CrossRefPubMed
18.
Zurück zum Zitat Vellas B, Villars H, Abellan G et al (2006) Overview of the MNA—its history and challenges. J Nutr Health Aging 10:456–463 (Discussion 463–455) PubMed Vellas B, Villars H, Abellan G et al (2006) Overview of the MNA—its history and challenges. J Nutr Health Aging 10:456–463 (Discussion 463–455) PubMed
19.
Zurück zum Zitat Kondrup J, Rasmussen HH, Hamberg O et al (2003) Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22:321–336CrossRefPubMed Kondrup J, Rasmussen HH, Hamberg O et al (2003) Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22:321–336CrossRefPubMed
20.
Zurück zum Zitat Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMed Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMed
21.
Zurück zum Zitat Nozoe T, Iguchi T, Egashira A et al (2011) Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma. Am J Surg 201:186–191CrossRefPubMed Nozoe T, Iguchi T, Egashira A et al (2011) Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma. Am J Surg 201:186–191CrossRefPubMed
22.
Zurück zum Zitat Imaoka H, Mizuno N, Hara K et al (2016) Evaluation of modified glasgow prognostic score for pancreatic cancer: a retrospective cohort study. Pancreas 45:211–217CrossRefPubMed Imaoka H, Mizuno N, Hara K et al (2016) Evaluation of modified glasgow prognostic score for pancreatic cancer: a retrospective cohort study. Pancreas 45:211–217CrossRefPubMed
23.
Zurück zum Zitat Nozoe T, Matono R, Ijichi H et al (2014) Glasgow prognostic score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma. Int Surg 99:512–517CrossRefPubMedPubMedCentral Nozoe T, Matono R, Ijichi H et al (2014) Glasgow prognostic score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma. Int Surg 99:512–517CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hirashima K, Watanabe M, Shigaki H et al (2014) Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol 49:1040–1046CrossRefPubMed Hirashima K, Watanabe M, Shigaki H et al (2014) Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol 49:1040–1046CrossRefPubMed
25.
Zurück zum Zitat Liu Z, Jin K, Guo M et al (2017) Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer. Ann Surg Oncol 24:561–568CrossRefPubMed Liu Z, Jin K, Guo M et al (2017) Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer. Ann Surg Oncol 24:561–568CrossRefPubMed
26.
Zurück zum Zitat Kim JH, Han DS, Bang HY et al (2015) Preoperative neutrophil-to-lymphocyte ratio is a prognostic factor for overall survival in patients with gastric cancer. Ann Surg Treat Res 89:81–86CrossRefPubMedPubMedCentral Kim JH, Han DS, Bang HY et al (2015) Preoperative neutrophil-to-lymphocyte ratio is a prognostic factor for overall survival in patients with gastric cancer. Ann Surg Treat Res 89:81–86CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Stotz M, Gerger A, Eisner F et al (2013) Increased neutrophil–lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109:416–421CrossRefPubMedPubMedCentral Stotz M, Gerger A, Eisner F et al (2013) Increased neutrophil–lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109:416–421CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Kumar R, Geuna E, Michalarea V et al (2015) The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. Br J Cancer 112:1157–1165CrossRefPubMedPubMedCentral Kumar R, Geuna E, Michalarea V et al (2015) The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. Br J Cancer 112:1157–1165CrossRefPubMedPubMedCentral
Metadaten
Titel
Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil–Lymphocyte Ratio in Gastric Cancer Patients
verfasst von
Hiroaki Saito
Yusuke Kono
Yuki Murakami
Yuji Shishido
Hirohiko Kuroda
Tomoyuki Matsunaga
Yoji Fukumoto
Tomohiro Osaki
Keigo Ashida
Yoshiyuki Fujiwara
Publikationsdatum
21.12.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 6/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4400-1

Weitere Artikel der Ausgabe 6/2018

World Journal of Surgery 6/2018 Zur Ausgabe

Innovative Surgical Techniques Around the World

Image-Guided Proper Liver Segmentectomy

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.